KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Debt to Equity (2016 - 2023)

Medpace Holdings filings provide 7 years of Debt to Equity readings, the most recent being $0.14 for Q2 2023.

  • On a quarterly basis, Debt to Equity fell 92.02% to $0.14 in Q2 2023 year-over-year; TTM through Jun 2023 was $0.14, a 92.02% decrease, with the full-year FY2022 number at $0.13, changed N/A from a year prior.
  • Debt to Equity hit $0.14 in Q2 2023 for Medpace Holdings, down from $0.33 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $1.76 in Q2 2022 to a low of $0.09 in Q1 2019.
  • Median Debt to Equity over the past 3 years was $0.24 (2023), compared with a mean of $0.48.
  • Biggest five-year swings in Debt to Equity: crashed 76.1% in 2019 and later crashed 92.02% in 2023.
  • Medpace Holdings' Debt to Equity stood at $0.09 in 2019, then skyrocketed by 44.27% to $0.13 in 2022, then increased by 8.69% to $0.14 in 2023.
  • The last three reported values for Debt to Equity were $0.14 (Q2 2023), $0.33 (Q1 2023), and $0.13 (Q4 2022) per Business Quant data.